CCM
ABBV icon

Collar Capital Management’s AbbVie ABBV Stock Holding History

Collar Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Sell
15,383
-8
-0.1% -$1.72K 2.28% 10
2026
Q1 		$3.35M Buy
15,391
+84
+0.5% +$18.6K 2.17% 17
2025
Q4 		$3.5M Buy
15,307
+4,065
+36% +$926K 2.34% 13
2025
Q3 		$2.6M Hold
11,242
– – 1.83% 22
2025
Q2 		$2.09M Buy
11,242
+34
+0.3% +$6.32K 1.76% 21
2025
Q1 		$2.35M Buy
11,208
+4,076
+57% +$792K 2.13% 14
2024
Q4 		$1.27M Buy
+7,132
New +$1.31M 1.06% 41

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Collar Capital Management's ABBV Position: Q2 2026 in Review

Collar Capital Management reduced its AbbVie (ABBV) stake by 0.05% in Q2 2026, selling an estimated $1.72K and leaving 15,383 shares worth $3.87M. The position accounts for 2.28% of the portfolio, ranked #10.

Collar Capital Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Collar Capital Management held 15,383 shares of AbbVie worth $3.87M as of Q2 2026.
  • Collar Capital Management sold 8 AbbVie shares in Q2 2026, an estimated $1.72K.
  • AbbVie made up 2.28% of Collar Capital Management's portfolio in Q2 2026, its #10 holding.
  • Collar Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Collar Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.